Q3 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CRTO | Sell | CRITEO S Aspons ads | $52,345,409 | -13.8% | 1,792,651 | -0.4% | 1.28% | -21.5% |
| CLLS | Exit | CELLECTIS S.A. | $0 | – | -2,186,960 | – | -0.12% | – |
Q2 2023
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STLA | New | STELLANTIS NV | $3,357,019,015 | – | 192,703,907 | – | 90.18% | – |
| CSTM | New | CONSTELLIUM NVcl a | $281,975,132 | – | 16,393,903 | – | 7.58% | – |
| CRTO | New | CRITEO S Aspons ads | $60,745,530 | – | 1,800,401 | – | 1.63% | – |
| New | MIRION TECHNOLOGIES INC | $10,870,469 | – | 1,286,446 | – | 0.29% | – | |
| SQNS | New | SEQUANSCOMMUNICATIONS S Aspons ads | $7,359,040 | – | 3,300,018 | – | 0.20% | – |
| CLLS | New | CELLECTIS S.A. | $4,302,844 | – | 2,186,960 | – | 0.12% | – |
| New | GETAROUND INC | $226,733 | – | 647,808 | – | 0.01% | – |
Q4 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Exit | MIRION TECHNOLOGIES INC | $0 | – | -1,286,446 | – | -0.37% | – | |
| SQNS | Exit | SEQUANSCOMMUNICATIONS S Aspons ads | $0 | – | -3,300,018 | – | -0.46% | – |
| VECT | Exit | VECTIVBIO HOLDING AG | $0 | – | -2,806,217 | – | -0.65% | – |
| CRTO | Exit | CRITEO S Aspons ads | $0 | – | -2,718,752 | – | -2.84% | – |
| CSTM | Exit | CONSTELLIUM NVcl a | $0 | – | -16,393,903 | – | -6.43% | – |
| STLA | Exit | STELLANTIS NV | $0 | – | -192,703,907 | – | -89.24% | – |
Q3 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -8,055 | – | -0.00% | – |
| CLLS | Exit | CELLECTISspons ads | $0 | – | -425,726 | – | -0.04% | – |
| VCYT | Exit | VERACYTE INTERNATIONAL | $0 | – | -152,261 | – | -0.11% | – |
Q2 2022
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STLA | New | STELLANTIS NV | $2,358,303,000 | – | 192,703,907 | – | 88.10% | – |
| CSTM | New | CONSTELLIUM NVcl a | $216,563,000 | – | 16,393,903 | – | 8.09% | – |
| CRTO | New | CRITEO S Aspons ads | $66,338,000 | – | 2,718,752 | – | 2.48% | – |
| VECT | New | VECTIVBIO HOLDING AG | $15,154,000 | – | 2,806,217 | – | 0.57% | – |
| SQNS | New | SEQUANSCOMMUNICATIONS S Aspons ads | $8,877,000 | – | 3,300,018 | – | 0.33% | – |
| New | MIRION TECHNOLOGIES INC | $7,410,000 | – | 1,286,446 | – | 0.28% | – | |
| VCYT | New | VERACYTE INTERNATIONAL | $3,030,000 | – | 152,261 | – | 0.11% | – |
| CLLS | New | CELLECTISspons ads | $1,205,000 | – | 425,726 | – | 0.04% | – |
| RPTX | New | REPARE THERAPEUTICS INC | $113,000 | – | 8,055 | – | 0.00% | – |
Q4 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CLLS | Exit | CELLECTISspons ads | $0 | – | -425,726 | – | -0.12% | – |
| SQNS | Exit | SEQUANS COMMUNICATIONS S Aspons ads | $0 | – | -3,300,018 | – | -0.33% | – |
| VECT | Exit | VECTIVBIO HOLDING AG | $0 | – | -2,806,217 | – | -0.50% | – |
| VCYT | Exit | VERACYTE INTERNATIONAL | $0 | – | -501,941 | – | -0.54% | – |
| CRTO | Exit | CRITEO S Aspons ads | $0 | – | -2,718,752 | – | -2.29% | – |
| FTI | Exit | TECHNIPFMC PLC | $0 | – | -24,688,691 | – | -4.30% | – |
| CSTM | Exit | CONSTELLIUM NVcl a | $0 | – | -16,393,903 | – | -7.06% | – |
| STLA | Exit | STELLANTIS NV | $0 | – | -192,703,907 | – | -84.86% | – |
Q3 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CSTM | New | CONSTELLIUM NVcl a | $307,877,000 | – | 16,393,903 | – | 7.06% | – |
| VCYT | New | VERACYTE INTERNATIONAL | $23,315,000 | – | 501,941 | – | 0.54% | – |
| SQNS | New | SEQUANS COMMUNICATIONS S Aspons ads | $14,487,000 | – | 3,300,018 | – | 0.33% | – |
| CRSP | Exit | CRISPR THERAPEUTICS AG | $0 | – | -4,800 | – | -0.02% | – |
| SQNS | Exit | SEQUANS COMMUNICATIONS S Aspons ads | $0 | – | -3,300,018 | – | -0.44% | – |
| CSTM | Exit | CONSTELLIUM NVcl a | $0 | – | -16,393,903 | – | -6.90% | – |
Q2 2021
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| STLA | New | STELLANTIS NV | $3,787,814,000 | – | 192,703,907 | – | 84.11% | – |
| CSTM | New | CONSTELLIUM NVcl a | $310,664,000 | – | 16,393,903 | – | 6.90% | – |
| FTI | New | TECHNIPFMC PLC | $221,928,000 | – | 24,688,691 | – | 4.93% | – |
| CRTO | New | CRITEO S Aspons ads | $122,969,000 | – | 2,718,752 | – | 2.73% | – |
| VECT | New | VECTIVBIO HOLDING AG | $32,720,000 | – | 2,806,217 | – | 0.73% | – |
| SQNS | New | SEQUANS COMMUNICATIONS S Aspons ads | $19,866,000 | – | 3,300,018 | – | 0.44% | – |
| CLLS | New | CELLECTISspons ads | $6,586,000 | – | 425,726 | – | 0.15% | – |
| CRSP | New | CRISPR THERAPEUTICS AG | $777,000 | – | 4,800 | – | 0.02% | – |
Q4 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -536,805 | – | -0.25% | – |
| CLLS | Exit | CELLECTISspons ads | $0 | – | -425,726 | – | -2.26% | – |
| SQNS | Exit | SEQUANS COMMUNICATIONS S Aspons ads | $0 | – | -3,378,963 | – | -5.78% | – |
| CRTO | Exit | CRITEO S Aspons ads | $0 | – | -2,718,752 | – | -9.50% | – |
| CSTM | Exit | CONSTELLIUM NVcl a | $0 | – | -16,393,903 | – | -36.91% | – |
| FTI | Exit | TECHNIPFMC PLC | $0 | – | -24,688,691 | – | -45.29% | – |
Q3 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SQNS | Sell | SEQUANS COMMUNICATIONS S Aspons ads | $20,172,000 | -4.8% | 3,378,963 | -2.1% | 5.78% | +10.7% |
| CLLS | New | CELLECTISspons ads | $7,876,000 | – | 425,726 | – | 2.26% | – |
| MLND | Sell | MILLENDO THERAPEUTICS INC | $875,000 | -53.9% | 536,805 | -50.2% | 0.25% | -46.4% |
| CRNX | Exit | CRINETICS PHARMACEUTICALS | $0 | – | -12,418 | – | -0.05% | – |
| TLND | Exit | TALEND S Aads | $0 | – | -1,612,895 | – | -13.79% | – |
Q2 2020
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FTI | New | TECHNIPFMC PLC | $169,362,000 | – | 24,688,691 | – | 41.77% | – |
| CSTM | New | CONSTELLIUM NVcl a | $125,905,000 | – | 16,393,903 | – | 31.05% | – |
| TLND | New | TALEND S Aads | $55,903,000 | – | 1,612,895 | – | 13.79% | – |
| CRTO | New | CRITEO S Aspons ads | $30,967,000 | – | 2,718,752 | – | 7.64% | – |
| SQNS | New | SEQUANS COMMUNICATIONS S Aspons ads | $21,185,000 | – | 3,450,259 | – | 5.22% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $1,898,000 | – | 1,078,670 | – | 0.47% | – |
| CRNX | New | CRINETICS PHARMACEUTICALS | $218,000 | – | 12,418 | – | 0.05% | – |
Q4 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MITK | Exit | MITEK SKS INC | $0 | – | -14,571 | – | -0.02% | – |
| MLND | Exit | MILLENDO THERAPEUTICS INC | $0 | – | -1,078,670 | – | -0.83% | – |
| SQNS | Exit | SEQUANS COMMUNICATIONS S Aspons ads | $0 | – | -12,085,561 | – | -1.14% | – |
| CRTO | Exit | CRITEO S Aspons ads | $0 | – | -2,718,752 | – | -5.50% | – |
| TLND | Exit | TALEND S Aads | $0 | – | -1,612,895 | – | -5.93% | – |
| CSTM | Exit | CONSTELLIUM NVcl a | $0 | – | -16,393,903 | – | -22.55% | – |
| FTI | Exit | TECHNIPFMC PLC | $0 | – | -24,688,691 | – | -64.04% | – |
Q2 2019
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FTI | New | TECHNIPFMC PLC | $634,964,000 | – | 24,688,691 | – | 68.13% | – |
| CSTM | New | CONSTELLIUM NVcl a | $164,595,000 | – | 16,393,903 | – | 17.66% | – |
| TLND | New | TALEND S Aads | $62,242,000 | – | 1,612,895 | – | 6.68% | – |
| CRTO | New | CRITEO S Aspons ads | $46,790,000 | – | 2,718,752 | – | 5.02% | – |
| MLND | New | MILLENDO THERAPEUTICS INC | $12,469,000 | – | 1,078,670 | – | 1.34% | – |
| SQNS | New | SEQUANS COMMUNICATIONS S Aspons ads | $10,756,000 | – | 12,085,561 | – | 1.15% | – |
| MITK | New | MITEK SKS INC | $145,000 | – | 14,571 | – | 0.02% | – |